Medical Devices Analytical Testing Outsourcing Market (2026 - 2033)

Medical Devices Analytical Testing Outsourcing Market Summary

The global medical devices analytical testing outsourcing market size was valued at USD 7.1 billion in 2025 and is projected to grow from USD 7.6 billion in 2026 to USD 13.0 billion by 2033, at a CAGR of 8.0% from 2026 to 2033. North America dominated the market, accounting for the largest share of 39.2% in 2025. The medical devices analytical testing outsourcing industry is experiencing steady growth, driven by increasingly stringent regulatory requirements for device safety and performance, rising complexity of medical device technologies, growing product development activities across diagnostic and therapeutic devices, increasing demand for biocompatibility and material characterization studies, and the continued outsourcing of specialized testing services to third-party laboratories. 

Medical device manufacturers are increasingly relying on external analytical testing providers to support product development, regulatory submissions, quality assurance programs, and post-market compliance activities while optimizing operational costs and accelerating time-to-market. The growing complexity of medical devices remains a key factor supporting market expansion. Advanced implantable devices, combination products, in vitro diagnostic (IVD) systems, minimally invasive surgical devices, and digitally enabled medical technologies require extensive analytical testing throughout the product lifecycle. Regulatory authorities increasingly require comprehensive evaluations related to chemical characterization, extractables and leachables, material composition, biocompatibility, sterilization validation, packaging integrity, and shelf-life performance.

As a result, manufacturers are seeking specialized analytical testing partners with advanced instrumentation, technical expertise, and regulatory experience to meet evolving compliance requirements. The increasing volume of regulatory submissions and product approvals continues to generate demand for outsourced analytical testing services. Medical device companies are expanding testing programs to address requirements under evolving regulatory frameworks, including risk-based assessments, material safety evaluations, and performance verification studies. Outsourcing enables manufacturers to access specialized capabilities and accredited laboratory infrastructure without substantial investments in internal testing facilities, thereby improving development efficiency and regulatory readiness.

This trend is reflected in ongoing investments by analytical testing service providers. For instance, in March 2025, NAMSA completed the acquisition of WuXi AppTec's U.S. medical device testing operations, expanding its laboratory capacity and strengthening capabilities in biocompatibility, extractables and leachables (E&L), microbiology, and preclinical testing. The acquisition enhanced NAMSA's ability to provide integrated analytical testing and regulatory support services to medical device manufacturers. Such expansions aim to address growing customer demand for comprehensive analytical testing solutions across the premarket and commercial stages. Increasing outsourcing among small and mid-sized medical device companies is another significant growth driver. Establishing and maintaining in-house analytical laboratories requires substantial capital expenditure for sophisticated instrumentation, laboratory accreditation, quality management systems, and highly skilled scientific personnel. Therefore, manufacturers increasingly partner with specialized testing organizations that offer broad technical capabilities, regulatory expertise, and established quality frameworks, enabling efficient execution of testing programs while maintaining compliance with global regulatory standards.

Market Dynamics

Market growth is moderated by the high cost of advanced analytical instrumentation, extended validation and accreditation timelines, evolving regulatory expectations across different jurisdictions, and a limited pool of specialized scientific professionals with expertise in medical device analytical testing and regulatory compliance. The increasing development of implantable devices, expansion of in vitro diagnostics and combination products, rising adoption of advanced materials in medical devices, growing regulatory scrutiny of product safety and material characterization, and continued outsourcing by both established manufacturers and emerging medical technology companies are expected to create substantial long-term opportunities for analytical testing service providers operating in the medical devices sector.

Market Concentration & Characteristics

The medical devices analytical testing outsourcing market growth stage is high, and the pace of growth is accelerating. The market is characterized by the degree of innovation, level of M&A activities, regulatory impact, service expansion, and regional expansion.

Innovation is a key competitive factor in the market, with laboratories continuously investing in advanced analytical instrumentation, automation, artificial intelligence-driven data analysis, and molecular characterization technologies. Growing demand for biologics, biosimilars, cell and gene therapies, and personalized medicines is encouraging the adoption of high-sensitivity analytical platforms that improve testing accuracy and laboratory efficiency. Continuous innovation enables service providers to expand specialized testing capabilities, improve turnaround times, and support evolving regulatory requirements, strengthening their competitive position.

Mergers and acquisitions continue to reshape the medical devices analytical testing outsourcing industry by expanding laboratory networks, strengthening technical capabilities, and broadening service portfolios. Strategic acquisitions enable analytical testing providers to access specialized expertise in bioanalytical testing, microbiology, material characterization, and advanced therapy testing while expanding their geographic presence. Such transactions also improve operational scale, increase customer reach, and strengthen competitive positioning in a rapidly evolving outsourcing market.

Regulatory compliance remains one of the most influential factors affecting the medical devices analytical testing outsourcing market. Laboratories must comply with Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), ISO standards, ICH guidelines, and requirements established by global regulatory authorities. Maintaining validated analytical methods, data integrity, laboratory accreditation, and comprehensive documentation increases operational complexity while creating opportunities for laboratories with strong regulatory expertise and established quality systems.

Healthcare analytical testing providers are expanding their service portfolios to support pharmaceutical, biotechnology, and medical device companies throughout the product lifecycle. Many laboratories now offer integrated services including bioanalytical testing, method development and validation, stability studies, extractables and leachables testing, microbiological testing, elemental impurity analysis, and regulatory support. Broader service capabilities improve customer retention, increase cross-selling opportunities, and enable providers to address a wider range of analytical requirements through a single service partner.

Regional expansion is enabling analytical testing providers to strengthen their presence in high-growth pharmaceutical manufacturing and biotechnology markets. Establishing new laboratories and expanding existing facilities across North America, Europe, Asia Pacific, Latin America, and the Middle East improves customer accessibility, reduces sample transportation timelines, and supports compliance with regional regulatory requirements. A broader laboratory network also enhances business continuity, strengthens global service delivery, and enables providers to support multinational pharmaceutical and medical device companies more effectively.

Analyst Perspective

The medical devices analytical testing outsourcing market is growing steadily as regulatory scrutiny intensifies and device technologies become more complex. Besides, the growing need for implantable devices, IVDs, cardiovascular products, orthopedic implants, wearables, minimally invasive devices, and combination products is expected to increase the demand for specialized services such as biocompatibility testing, chemical characterization, extractables and leachables studies, microbiological testing, sterility assurance, packaging validation, and material analysis. In addition, the manufacturers are increasingly preferring accredited external laboratories to access advanced instrumentation, specialized expertise, independent validation, and regulatory support without maintaining extensive in-house capabilities. Compliance with U.S. FDA requirements, EU MDR, IVDR, and ISO standards is also driving laboratories to adopt automation, LIMS, and digital quality systems that improve efficiency, traceability, and data integrity. Providers with integrated service portfolios, accredited quality systems, broad geographic laboratory networks, and strong regulatory expertise are expected to gain a competitive advantage and capture a larger market share.

Impact of U.S. Tariffs on the Global Medical Devices Analytical Testing Outsourcing Market

The imposition of U.S. tariffs on imported laboratory instruments, analytical equipment, electronic components, specialty chemicals, and laboratory consumables has increased procurement and operating costs for medical device analytical testing laboratories. Higher prices for chromatography systems, mass spectrometers, spectroscopy instruments, microbiological testing equipment, and certified reference materials have increased capital investment requirements and routine operating expenses for testing service providers. Laboratories that rely on imported reagents, testing consumables, and precision instrument components have also experienced supply chain disruptions and extended procurement timelines, affecting laboratory productivity and project scheduling.

Medical device manufacturers may experience higher analytical testing costs during product development, verification and validation, biocompatibility assessment, chemical characterization, and regulatory submission activities. In response, analytical testing service providers have diversified supplier networks, expanded local sourcing strategies, strengthened inventory management practices, and invested in regional laboratory infrastructure to reduce supply chain risks. At the same time, manufacturers of analytical instruments have increased regional manufacturing and assembly operations to mitigate tariff-related cost pressures. Despite these challenges, demand for outsourced analytical testing services is expected to remain strong, driven by increasingly stringent regulatory requirements, growing medical device innovation, and manufacturers' continued outsourcing to secure specialized technical expertise and faster regulatory approvals. Investments in domestic laboratory capacity and localized supply chains are expected to improve operational resilience while supporting the long-term market growth.

Technological Advancements

Technological advancements continue to reshape the medical devices analytical testing outsourcing industry by improving laboratory efficiency, analytical precision, and regulatory compliance. The adoption of sophisticated analytical instrumentation has strengthened the industry's ability to evaluate increasingly complex medical devices and materials. Automation enables laboratories to process larger testing volumes while maintaining high reproducibility and operational consistency. Digital laboratory platforms are improving data management, documentation, and audit preparedness, supporting compliance with evolving global quality standards. At the same time, advancements in chemical characterization and biological safety assessment are helping manufacturers address more rigorous regulatory expectations for product safety and performance. The incorporation of artificial intelligence and data-driven laboratory tools is further enhancing productivity by simplifying analytical workflows and improving decision support. These innovations are enabling contract testing organizations to expand their service offerings while reducing customer turnaround times.

Medical device manufacturers are increasingly selecting outsourcing partners with advanced technological capabilities to support complex product development programs and global regulatory submissions. Continued investment in laboratory modernization is expected to strengthen testing capacity and improve service quality across the industry. As medical device technologies continue to evolve, analytical testing requirements are becoming more specialized, reinforcing the need for continuous technological advancement. Laboratories that invest in advanced instrumentation, digital infrastructure, and automation are expected to strengthen their competitive position. Overall, technological innovation is improving the efficiency, scalability, and reliability of outsourced analytical testing services, supporting the sustained growth of the global market.

Pricing Model Analysis

The pricing structure in the medical devices analytical testing outsourcing market is influenced by the scope of testing, regulatory complexity, technology requirements, and project duration. Laboratories typically adopt multiple pricing approaches to accommodate the diverse needs of medical device manufacturers across development and commercialization stages. Fee-for-service remains the preferred model for routine analytical testing and individual laboratory assessments due to its flexibility and transparency. Project-based pricing is widely used for comprehensive testing programs that require a clearly defined scope and budget. Long-term service agreements are becoming increasingly common among large manufacturers seeking consistent testing support, priority laboratory access, and cost efficiencies over extended periods.

Customized pricing addresses specialized projects involving innovative devices, combination products, or non-standard regulatory requirements where testing protocols vary considerably. Turnaround time commitments, sample volumes, method development requirements, validation activities, and reporting expectations also influence the final pricing structure. Laboratories with specialized expertise, accredited quality systems, and advanced analytical capabilities are generally able to command premium pricing for technically demanding services. As medical devices become more sophisticated and regulatory expectations continue to evolve, pricing models are increasingly reflecting the level of scientific expertise and laboratory resources required for successful project execution. The continued expansion of outsourced testing is encouraging providers to offer flexible commercial arrangements that balance cost efficiency with technical quality and regulatory compliance. Overall, diversified pricing models enable analytical testing organizations to serve a broad customer base while supporting sustainable revenue generation and long-term client relationships.

Service Insights

The material characterization segment led the market with the largest revenue share of 25.3% in 2025. The segment's leading position is primarily attributed to the growing use of advanced polymers, metals, ceramics, coatings, and composite materials in medical devices, all of which require comprehensive characterization to verify their chemical, physical, and mechanical properties. Material characterization plays a critical role in demonstrating product safety, quality, consistency, and compliance throughout device development and commercialization. Manufacturers increasingly rely on outsourced laboratories for analytical techniques such as spectroscopy, chromatography, microscopy, elemental analysis, thermal analysis, and surface characterization to support product design, regulatory submissions, process validation, and failure investigations. The growing complexity of implantable devices, cardiovascular products, orthopedic implants, drug-device combination products, and minimally invasive devices has further increased the need for specialized material testing capabilities. In addition, evolving regulatory expectations regarding material composition, impurities, and long-term device performance continue to drive demand for comprehensive characterization services. The expansion of medical device innovation and increasing outsourcing of analytical activities are expected to support the continued leadership of the material characterization segment over the forecast period.

The bioburden testing segment is projected to witness the fastest growth during the forecast period. Rising production of sterile and implantable medical devices, together with increasing regulatory emphasis on microbiological quality assurance, is driving demand for outsourced bioburden testing services. Manufacturers are placing greater focus on monitoring microbial contamination throughout raw material evaluation, manufacturing processes, packaging validation, and finished product testing to ensure product safety and compliance with international quality standards.

Therapeutic Area Insights

The cardiology segment led the medical devices analytical testing outsourcing industry with the largest revenue share of 22.1% in 2025. The segment is driven by the high volume of cardiovascular devices, including stents, heart valves, catheters, pacemakers, and vascular grafts, all of which require extensive analytical and regulatory testing before commercialization. Material characterization, biocompatibility, sterility, and performance testing are essential to ensure device safety, reliability, and compliance. The increasing prevalence of cardiovascular diseases and continued innovation in minimally invasive cardiac devices continue to support demand for outsourced analytical testing services.

The general & plastic surgery segment is projected to witness the fastest growth during the forecast period. Rising demand for surgical instruments, wound closure products, meshes, tissue repair materials, and aesthetic medical devices is increasing the need for analytical testing throughout product development and manufacturing. Manufacturers are increasingly outsourcing testing to meet regulatory requirements while reducing development timelines and costs. Growing surgical procedure volumes, expanding adoption of minimally invasive techniques, and continuous product innovation are expected to drive strong growth in outsourced analytical testing for this therapeutic area.

End Use Insights

The hospital segment led the market with the largest revenue share of 87.0% in 2025. Hospitals are the primary end users of a wide range of medical devices, including surgical instruments, implants, diagnostic equipment, and patient monitoring systems, thereby creating sustained demand for high-quality, regulatory-compliant products. This drives the need for extensive analytical testing to ensure device safety, performance, sterility, and material integrity before commercialization. The increasing adoption of advanced medical technologies and the growing volume of surgical and diagnostic procedures continue to support the dominance of the hospital segment.

The other end-use segment is expected to register the second-fastest growth during the forecast period. Growing demand for point-of-care diagnostics, minimally invasive procedures, and portable medical devices is driving the need for outsourced analytical testing services across other end users. In addition, expanding healthcare infrastructure and the increasing adoption of innovative medical technologies across non-hospital settings are expected to support the segment's growth.

Device Type Insights

The others segment led the market with the largest revenue share of 78.1% in 2025. The segment comprises a broad range of medical devices, including diagnostic consumables, wound care products, ophthalmic devices, dental devices, infusion products, and other specialized equipment, collectively generating significant testing demand. These products require comprehensive analytical evaluation for material characterization, microbiological quality, sterility, chemical safety, and performance verification to comply with regulatory requirements. The large volume and diversity of devices within this category continue to support its leading position in the market.

The reprocessed devices segment is expected to register the fastest CAGR during the forecast period. The growing adoption of reprocessed single-use medical devices by healthcare providers to reduce costs and minimize medical waste is increasing the demand for specialized analytical testing services. Reprocessed devices must undergo rigorous evaluation for cleanliness, sterility, material integrity, functional performance, and residual contamination to demonstrate that they meet the same safety and quality standards as new devices. Increasing regulatory oversight and standardized validation requirements for reprocessed medical devices are further encouraging manufacturers and third-party reprocessors to outsource analytical testing to specialized laboratories, supporting the segment's growth.

Regional Insights

The North America medical devices analytical testing outsourcing market dominated with the largest revenue share of 39.2% in 2025.The regional market is supported by a well-established medical device industry, stringent regulatory requirements, and the presence of leading analytical testing laboratories and contract testing organizations. Growing development of implantable devices, in vitro diagnostics (IVDs), cardiovascular devices, orthopedic implants, wearable medical technologies, and combination products continues to increase demand for biocompatibility testing, chemical characterization, extractables and leachables (E&L) studies, microbiological testing, sterility assurance, and packaging validation. In addition, evolving regulatory requirements under the U.S. FDA and Health Canada are encouraging manufacturers to adopt comprehensive analytical testing throughout product development and commercialization. The increasing outsourcing of analytical testing activities to accredited laboratories that offer specialized expertise, advanced instrumentation, and regulatory support is further contributing to market growth. Continued investments in laboratory automation, digital laboratory management systems, and advanced analytical technologies are expected to support regional expansion throughout the forecast period.

U.S. Medical Devices Analytical Testing Outsourcing Market Trends

The U.S. medical devices analytical testing outsourcing industry held the largest share of North America in 2025. Market growth is driven by the presence of leading medical device manufacturers, established contract testing organizations, and a robust regulatory framework governing product safety and quality. Increasing development of implantable devices, minimally invasive technologies, digital health products, and combination devices is driving demand for specialized analytical testing services, including biocompatibility assessment, chemical characterization, microbiological testing, particulate analysis, and extractables and leachables studies. Manufacturers are increasingly outsourcing analytical testing to improve regulatory compliance, reduce capital investment, and accelerate product development timelines. Ongoing investments by testing providers in laboratory expansion, automation, and advanced analytical instrumentation are expected to support sustained market growth.

The Canada medical devices analytical testing outsourcing market is expected to grow at a significant CAGR during the forecast period.Growth is supported by increasing investment in medical technology innovation, expanding medical device manufacturing activities, and continued government support for healthcare research and life sciences. Rising demand for implantable devices, diagnostic technologies, and combination products is increasing the need for specialized analytical services, including biocompatibility testing, microbiological evaluation, material characterization, and packaging validation. Furthermore, Canada's strong regulatory environment, skilled scientific workforce, and expanding laboratory infrastructure continue to attract outsourcing from domestic and international medical device manufacturers. Ongoing investments in advanced analytical capabilities are expected to support market growth over the forecast period.

Europe Medical Devices Analytical Testing Outsourcing Market Trends

The Europe medical devices analytical testing outsourcing industry is experiencing steady growth, supported by a strong medical device manufacturing base, stringent regulatory standards, and increasing demand for independent testing and certification services. The implementation of the European Union Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR) has significantly increased demand for analytical testing, including biocompatibility assessments, chemical characterization, extractables and leachables studies, microbiological testing, and packaging validation. The region also benefits from the presence of globally recognized analytical testing organizations and specialized laboratories serving medical device manufacturers across multiple therapeutic areas. Continued expansion of laboratory infrastructure, increasing outsourcing of testing activities, and growing investment in advanced analytical technologies are expected to support market growth throughout the forecast period.

The medical devices analytical testing outsourcing market in Germany held the largest share in Europe in 2025. The country benefits from one of Europe's largest medical device manufacturing industries, a well-developed analytical laboratory infrastructure, and strong regulatory compliance capabilities. Increasing production of orthopedic implants, cardiovascular devices, surgical instruments, diagnostic equipment, and combination products is driving demand for analytical testing services, including material characterization, biocompatibility evaluation, microbiological testing, sterility assurance, and chemical analysis. Continued investment in laboratory modernization and advanced analytical technologies is expected to support market expansion during the forecast period.

The UK medical devices analytical testing outsourcing market is expected to grow significantly over the forecast period.Market expansion is supported by a well-established medical technology sector, increasing innovation in diagnostic devices, digital health technologies, and implantable medical devices, and the presence of leading analytical testing laboratories. The growing demand for outsourced services in biocompatibility testing, chemical characterization, microbiological analysis, packaging validation, and regulatory compliance is encouraging laboratories to expand their technical capabilities. In addition, continued investment in healthcare innovation, research collaborations, and laboratory infrastructure is expected to contribute to sustained market growth during the forecast period.

Asia Pacific Medical Devices Analytical Testing Outsourcing Market Trends

Asia Pacific is expected to grow at a significant CAGR over the forecast period. Market growth is supported by expanding medical device manufacturing, increasing investment in healthcare technologies, improving laboratory infrastructure, and favorable government initiatives promoting domestic medical device production. The rising outsourcing of analytical testing by global medical device manufacturers to countries with skilled scientific professionals, accredited laboratories, and cost-effective testing services is driving regional demand. Furthermore, increasing production of implantable devices, in vitro diagnostics (IVDs), wearable medical devices, and combination products is generating higher demand for biocompatibility testing, chemical characterization, extractables and leachables (E&L) studies, microbiological testing, sterility assurance, and packaging validation. Continued investment in laboratory modernization, advanced analytical instrumentation, and internationally accredited quality systems is expected to support long-term market growth across the region.

The medical devices analytical testing outsourcing market in China is witnessing strong growth due to expanding medical device manufacturing, increasing investment in healthcare innovation, and rising outsourcing by multinational medical device companies. Government initiatives supporting the domestic medical technology sector, improvements in regulatory oversight, and growing production of implantable devices, diagnostic equipment, and combination products are increasing demand for specialized analytical testing services. In addition, the expansion of ISO-compliant testing laboratories, the adoption of advanced analytical technologies, and the strengthening of regulatory capabilities continue to position China as a major analytical testing hub in the Asia Pacific region.

The medical devices analytical testing outsourcing market in Japan is driven by a well-established medical device industry, advanced analytical laboratory capabilities, and stringent regulatory standards for product quality and safety. Increasing development of high-value implantable devices, diagnostic systems, robotic surgical equipment, and digital healthcare technologies is creating sustained demand for biocompatibility testing, chemical characterization, microbiological analysis, and material testing services. Ongoing investment in laboratory modernization and advanced analytical instrumentation is expected to support continued market growth throughout the forecast period.

The India medical devices analytical testing outsourcing market is experiencing rapid growth driven by expanding domestic medical device manufacturing, increasing contract testing activities, and the availability of a large pool of skilled scientific professionals. Rising production of diagnostic devices, surgical instruments, implantable products, and consumables is driving demand for analytical testing across product development, regulatory approval, and commercial manufacturing. In addition, government initiatives such as the Production Linked Incentive (PLI) Scheme and continued investment in medical device parks, laboratory infrastructure, and quality systems are expected to strengthen India's position as a preferred outsourcing destination over the forecast period.

Latin America Medical Devices Analytical Testing Outsourcing Market Trends

The Latin America medical devices analytical testing outsourcing industry is expected to grow steadily during the forecast period. Growth is supported by expanding medical device manufacturing, increasing healthcare investments, and rising adoption of international quality and regulatory standards across the region. Countries such as Brazil and Argentina are strengthening analytical laboratory capabilities while attracting outsourcing from multinational medical device manufacturers seeking cost-effective testing services. Increasing emphasis on product safety, regulatory compliance, and quality assurance is expected to contribute to sustained market expansion.

Brazil medical devices analytical testing outsourcing market is driven by growing medical device production, increasing investment in healthcare infrastructure, and supportive government initiatives for the domestic medical technology sector. Rising outsourcing of analytical testing by local and international manufacturers is increasing demand for biocompatibility assessment, microbiological testing, chemical characterization, sterility assurance, and packaging validation services. Continued expansion of accredited laboratory infrastructure and increasing collaboration between domestic and global healthcare companies are expected to support long-term market growth.

Middle East & Africa Medical Devices Analytical Testing Outsourcing Market Trends

The Middle East & Africa medical devices analytical testing outsourcing industry is expected to grow steadily over the forecast period. The market is supported by increasing healthcare expenditure, expansion of the regional medical device industry, and growing investment in healthcare infrastructure and life sciences. Rising regulatory requirements, increasing imports and local production of medical devices, and greater adoption of outsourced analytical testing services are driving regional demand. Continued investment in accredited laboratories, quality management systems, and advanced analytical technologies is expected to create additional opportunities for testing service providers.

The UAE medical devices analytical testing outsourcing market is experiencing steady growth driven by increasing investment in healthcare infrastructure, the expansion of the medical technology sector, and government initiatives aimed at strengthening life sciences and advanced healthcare services. The growing demand for internationally compliant analytical testing services for medical devices, coupled with the increasing adoption of global quality standards and the expansion of laboratory capabilities, is supporting market growth. In addition, rising partnerships between regional healthcare organizations and international testing providers are expected to contribute to sustained market expansion over the forecast period.

Key Medical Devices Analytical Testing Outsourcing Company Insights

The key players operating across the market are adopting strategic initiatives such as service launches, mergers & acquisitions, partnerships & agreements, and expansions to gain a competitive edge in the market. For instance, in June 2025, Nelson Labs announced a major expansion of its Salt Lake City, Utah, facility by doubling its ISO-classified cleanroom capacity. The expansion enhances the company's sterility assurance and microbiological testing capabilities to address increasing demand from medical device manufacturers for outsourced analytical testing services.

Key Medical Devices Analytical Testing Outsourcing Companies

The following key companies have been profiled for this study of the medical devices analytical testing outsourcing market.

• SGS Société Générale de Surveillance SA

• Toxikon, Inc. (Laboratory Corporation of America Holdings)

• Eurofins Scientific

• Pace Analytical Services, LLC

• Intertek Group plc

• Wuxi AppTec

• North American Science Associates, LLC

• Envigo (Inotiv)

• Charles River Laboratories 

Recent Developments

• In August 2025, Nelson Labs expanded its Wiesbaden, Germany laboratory by adding new capabilities for packaging validation, microbiological testing, endotoxin testing, bioburden testing, and ethylene oxide (EtO) residual analysis. The expansion strengthens the company's analytical testing capacity to support medical device manufacturers seeking regulatory-compliant testing services across Europe.

• In June 2025, Intertek strengthened its medical device testing capabilities through the acquisition of ATOR Labs' Automated Breathing Metabolic Simulator (ABMS). The technology enhances precision testing for respirators and respiratory protective devices, enabling manufacturers to accelerate product development and comply with global performance and safety standards.

Medical Devices Analytical Testing Outsourcing Market Report Scope

Global Medical Devices Analytical Testing Outsourcing Market Report Segmentation

This report forecasts revenue growth at the global, regional & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global medical devices analytical testing outsourcing market report based on service, therapeutic area, end use, device type, and region:

• Service Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Extractable and Leachable

  • Material Characterization

  • Physical Testing

  • Bioburden Testing

  • Sterility Testing

  • Other Tests

• Therapeutic Area Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Cardiology

  • Diagnostic Imaging

  • Orthopedic

  • IVD

  • Ophthalmic

  • General & Plastic Surgery

  • Drug Delivery

  • Endoscopy

  • Dental

  • Diabetes Care

  • Others

• End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Hospital

    • Equipment

    • Consumables

      • Syringes

      • Wound Care

      • Others

  • Others

• Device Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Reprocessed Devices

    • Hospital

    • Others

  • Others

• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • UAE

    • Saudi Arabia

    • Kuwait

    • Qatar

    • Oman

Research Methodology

The medical devices analytical testing outsourcing market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each medical devices analytical testing outsourcing segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations